It has been shown that PSGL-1-mediated interactions between multiple myeloma (MM) cells and macrophages increased ERK1/2 activation, myc upregulation, proliferation, and drug resistance in MM cells (167). The gene discussed is MAPK3; the disease is Miyoshi myopathy.